Post-surgical Outcomes With Anabolic Agent Use in High-risk Ankle Fractures: A Pilot RCT

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

June 1, 2027

Conditions

Ankle Fractures

Interventions

DRUG

subcutaneous Teriparatide injection

20 µg subcutaneous (SC) Teriparatide injection

OTHER

placebo

placebo 20 µg subcutaneous saline placebo injection once daily for 3 months in the post-operative ankle fracture population.

All Listed Sponsors

lead

University of Calgary

OTHER

NCT06303284 - Post-surgical Outcomes With Anabolic Agent Use in High-risk Ankle Fractures: A Pilot RCT | Biotech Hunter | Biotech Hunter